Dr. Studer is a scientific co-founder of BlueRock Therapeutics and is director of the Center for Stem Cell Biology and member of the Developmental Biology Program at Memorial Sloan Kettering in New York. He is currently leading a multidisciplinary consortium to pursue the clinical application of human stem cell-derived dopamine neurons for the treatment of Parkinson’s disease.
Dr. Studer trained as postdoctoral fellow at the National Institutes of Health, pioneering the therapeutic application of neural stem cell-derived neurons in models of neurodegeneration. As a native of Switzerland, he received his MD and doctorate degree from the University of Bern, where he got involved in developing cell-based therapies for Parkinson’s disease.
Dr. Studer’s work has been recognized by numerous awards including the Boyer Young Investigator award, the Annemarie Opprecht Award and a McArthur Fellowship.